当前位置:首页 - 行情中心 - 南模生物(688265) - 财务分析 - 现金流量表

南模生物

(688265)

  

流通市值:34.91亿  总市值:34.91亿
流通股本:7796.35万   总股本:7796.35万

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金169,082,455.973,803,262.03429,553,758.31273,931,584.88
  收到其他与经营活动有关的现金7,870,948.486,291,233.0612,441,880.739,099,991.97
  经营活动现金流入小计176,953,404.3880,094,495.09441,995,639.04283,031,576.85
  购买商品、接受劳务支付的现金72,180,284.1331,386,970.5393,207,697.2368,810,042.45
  支付给职工以及为职工支付的现金111,811,803.7764,095,373.35170,778,214.54143,887,427.6
  支付的各项税费1,427,947.91996,403.013,561,241.412,626,197.93
  支付其他与经营活动有关的现金32,383,612.3218,993,698.7677,529,239.2948,066,825.91
  经营活动现金流出小计217,803,648.13115,472,445.65345,076,392.47263,390,493.89
  经营活动产生的现金流量净额-40,850,243.75-35,377,950.5696,919,246.5719,641,082.96
二、投资活动产生的现金流量:
  收回投资收到的现金1,051,492,778.59659,123,965.032,964,732,447.572,351,180,132.49
  取得投资收益收到的现金--45,827.7245,827.72
  处置固定资产、无形资产和其他长期资产收回的现金净额13,623.8513,623.8542,521.5223,416.55
  投资活动现金流入小计1,051,506,402.44659,137,588.882,964,820,796.812,351,249,376.76
  购建固定资产、无形资产和其他长期资产支付的现金40,807,570.6823,405,297.5845,611,357.4619,621,909.64
  投资支付的现金927,000,000427,000,0003,044,400,0002,413,100,000
  投资活动现金流出小计967,807,570.68450,405,297.583,090,011,357.462,432,721,909.64
  投资活动产生的现金流量净额83,698,831.76208,732,291.3-125,190,560.65-81,472,532.88
三、筹资活动产生的现金流量:
  收到其他与筹资活动有关的现金4,204,886.4---
  筹资活动现金流入平衡项目0---
  筹资活动现金流入小计4,204,886.4---
  支付其他与筹资活动有关的现金9,833,077.483,645,586.1620,406,417.3214,702,993.05
  筹资活动现金流出小计9,833,077.483,645,586.1620,406,417.3214,702,993.05
  筹资活动产生的现金流量净额-5,628,191.08-3,645,586.16-20,406,417.32-14,702,993.05
四、汇率变动对现金及现金等价物的影响-2,577,098.86-1,314,584.34-1,747,828.67-672,617.2
五、现金及现金等价物净增加额34,643,298.07168,394,170.24-50,425,560.07-77,207,060.17
  加:期初现金及现金等价物余额145,789,285.53145,861,947.93196,214,845.6196,214,845.6
  期末现金及现金等价物余额180,432,583.6314,256,118.17145,789,285.53119,007,785.43
补充资料:
  净利润9,076,619.83-31,436,529.76-
  资产减值准备3,837,895.8-2,099,198.48-
  固定资产和投资性房地产折旧15,746,444.04-30,649,323.29-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧15,746,444.04-30,649,323.29-
  无形资产摊销3,741,743.37-7,453,406.88-
  长期待摊费用摊销6,939,959.33-16,347,834.36-
  处置固定资产、无形资产和其他长期资产的损失---38,969.27-
  固定资产报废损失7,869-171,471.78-
  公允价值变动损失-7,704,944.58--17,682,289.12-
  财务费用3,764,387.62-3,885,942.08-
  投资损失-589,073.61--1,775,193.98-
  递延所得税-1,225,213.86--2,341,263.19-
  其中:递延所得税资产减少-1,327,615.55--1,858,180.38-
    递延所得税负债增加102,401.69--483,082.81-
  存货的减少-18,844,202.38--8,144,990.77-
  经营性应收项目的减少-69,213,937.96--14,705,115.34-
  经营性应付项目的增加-3,438,642.32-28,354,234.26-
  其他5,261,111.75--6,017,825.75-
  不涉及现金收支的投资和筹资活动金额其他项目5,272,099.42-698,517.34-
  现金的期末余额180,432,583.6-145,789,285.53-
  减:现金的期初余额145,789,285.53-196,214,845.6-
  现金及现金等价物的净增加额34,643,298.07--50,425,560.07-
公告日期2026-08-292026-04-302026-04-272025-10-30
审计意见(境内)标准无保留意见
TOP↑